Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 076417
Company: WATSON LABS
Company: WATSON LABS
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| ANAGRELIDE HYDROCHLORIDE | ANAGRELIDE HYDROCHLORIDE | EQ 0.5MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
| ANAGRELIDE HYDROCHLORIDE | ANAGRELIDE HYDROCHLORIDE | EQ 1MG BASE | CAPSULE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 04/18/2005 | ORIG-1 | Approval |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/076417ltr.pdf |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 02/17/2026 | SUPPL-1 | Labeling-Package Insert |
Label is not available on this site. |